http://www.cellectar.com
Cellectar Biosciences, Inc. Company Intro
Cellectar Biosciences is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer.
Industry
Healthcare
Cellectar Biosciences, Inc. Headquaters
100 Campus Drive
Florham Park,07932
United States
Cellectar Biosciences, Inc. Share price
17 May 2023 12:59 GMT
$1.3800
0.0 (0.0 %)
Cellectar Biosciences, Inc. Market cap
$13.52 M
WMC RANKING
2023
Cellectar Biosciences, Inc. # 394
BiotechnologyLatest Cellectar Biosciences, Inc. News
03 Oct 2023
Relapsing Refractory Multiple Myeloma Pipeline Report, 2023 ...
CART-ddBCMA: Arcellx, Inc. Elranatamab: Pfizer; Mezigdomide: Bristol-Myers Squibb; Iopofosine: Cellectar Biosciences, Inc. ORIC-533: ORIC Pharmaceuticals.
03 Oct 2023
Relapsing Refractory Multiple Myeloma Pipeline Report, 2023 ...
CART-ddBCMA: Arcellx, Inc. Elranatamab: Pfizer; Mezigdomide: Bristol-Myers Squibb; Iopofosine: Cellectar Biosciences, Inc. ORIC-533: ORIC Pharmaceuticals.
02 Oct 2023
Cellectar Biosciences (CLRB) Expands Global Intellectual ...
Cellectar Biosciences (CLRB) Expands Global Intellectual Property Portfolio with Four Patent Grants. October 2, 2023 6:55 AM. Cellectar Biosciences, Inc.
WMC Market Score
WMC Market to Revenue Score
Cellectar Biosciences, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Cellectar Biosciences, Inc. | USD | $0 | $17,691 | $-17,494 | $135M | 394 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Cellectar Biosciences, Inc. Social Followers vs Top 4 Industry Competitors
Cellectar Biosciences, Inc. Post vs Top 4 Industry Competitors
Cellectar Biosciences, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Cellectar Biosciences, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Cellectar Biosciences, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Cellectar Biosciences, Inc. | 0 | 0.97 | 0.06 | 0 | 0 | 0 | 0.44 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
